Addressing the Challenge of Common Chronic Diseases — A View from the FDA-Reference-Cited by-同舟云学术

Addressing the Challenge of Common Chronic Diseases — A View from the FDA

Published:2024-02-08 Issue:6 Volume:390 Page:490-492
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Warraich Haider J.¹,Marston Hilary D.¹,Califf Robert M.¹

Affiliation:

1. From the Food and Drug Administration, Silver Spring, MD.

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp2313217

Reference5 articles.

1. Multimorbidity and social determinants of health in the US prior to the COVID-19 pandemic and implications for health outcomes: a cross-sectional analysis based on NHANES 2017–2018

2. Rural-Urban Disparity in Mortality in the US From 1999 to 2019

3. Differences in Health Outcomes between Men and Women: Biological, Behavioral, and Societal Factors

4. Using artificial intelligence and machine learning in the development of drug and biological products: discussion paper and request for feedback. Silver Spring MD: Food and Drug Administration May 11 2023 (https://www.fda.gov/media/167973/download).

5. 2015-2019 drug trials snapshots summary report: five-year summary and analysis of clinical trial participation and demographics. Silver Spring MD: Food and Drug Administration November 2020 (https://www.fda.gov/media/143592/download).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study;European Journal of Internal Medicine;2024-07

2. Perspective Chapter: Patient Advocacy - From a Seat at the Table to Equal Stakeholders; Economics of Healthcare, Studies and Cases [Working Title];2024-05-23

3. The Rise of 2 Interacting Subspecialties in Cardiology;Journal of the American College of Cardiology;2024-05

4. Single-patient trial of dietary protein restriction in kidney disease: a patient-centred opportunity;Clinical Kidney Journal;2024-03-30

5. Postmarketing Vaccine Safety Assessments;JAMA;2024-03-19